Anti-Small Cell Lung Carcinoma Antigen Antibody [MOC-52] (A250924)

Anti-Small Cell Lung Carcinoma Antigen Antibody [MOC-52]

Mouse monoclonal [MOC-52] antibody to Small Cell Lung Carcinoma Antigen.

This antibody reacts with a membrane-associated protein present in normal and malignant neuroendocrine tissues including small cell lung cancer (SCLC). It stains neural and a variable number of endocrine tissues and in the lung it reacts preferentially with SCLC and carcinoids. Its epitope is destroyed during formalin fixation. This antibody was categorized during the First International Workshop on Small Cell Lung Cancer Antigens held in London in April 1987. There are two major types of Lung Carcinoma: non-small cell, which accounts for 80% of all cases; and small cell, which accounts for roughly 20% of all lung cancers reported. The lung continues to be a customary place for cancer migration from tumors elsewhere in the body. Treatment depends on the specific cell type of the cancer, level of progression and status of the individual patient.

IF, ICC

IF: 1-2 µg/ml, ICC: 1-2 µg/ml

Human

Lung cancer-associated antigen isolated from small cell lung carcinoma-derived cell line.

Mouse

Monoclonal

MOC-52

IgG1

Unconjugated

Protein A/G chromatography.

200 µg/ml

145 kDa

Liquid

Supplied in 10mM Phosphate Buffered Saline with 0.05% BSA and 0.05% Sodium Azide.

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

This monoclonal antibody is also available in a different formulation without BSA and Sodium Azide - Anti-Small Cell Lung Carcinoma Antigen Antibody [MOC-52] - BSA and Azide free (A254104).